Phase 2 × Central Nervous System Neoplasms × Temozolomide × Clear all Temozolomide and Radiation Therapy in Treating Patients With Gliomas
Phase 2 Completed
136 enrolled 9 charts
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
Phase 2 Completed
118 enrolled 8 charts
O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors
Phase 2 Completed
41 enrolled 9 charts
Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
Phase 2 Completed
178 enrolled 23 charts
Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases
Phase 2 Completed
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
Phase 2 Completed
108 enrolled 14 charts
HeatShock
Phase 2 Completed
70 enrolled 12 charts
Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Phase 2 Completed
70 enrolled 18 charts
Temozolomide in Treating Patients With Invasive Pituitary Tumors
Phase 2 Withdrawn
TAVAREC
Phase 2 Completed
155 enrolled
Temozolomide in Treating Patients With Low-Grade Glioma
Phase 2 Completed
120 enrolled 8 charts
Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
Phase 2 Completed
29 enrolled
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Phase 2 Completed
111 enrolled
Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma
Phase 2 Completed
82 enrolled
Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme
Phase 2 Terminated
15 enrolled
Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor
Phase 2 Completed
44 enrolled
Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 2 Completed
32 enrolled
Temozolomide in Treating Patients With Recurrent High-Grade Glioma
Phase 2 Completed
60 enrolled 9 charts
Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme
Phase 2 Completed
110 enrolled
Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 2 Completed
O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy
Phase 2 Terminated
12 enrolled 10 charts
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Phase 2 Completed
47 enrolled 7 charts
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
Phase 2 Withdrawn
Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
Phase 2 Withdrawn
Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma
Phase 2 Completed
15 enrolled 9 charts
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
Phase 2 Completed
100 enrolled
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 2 Completed
170 enrolled
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
Phase 2 Unknown
80 enrolled
Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase 2 Unknown
Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma
Phase 2 Unknown
87 enrolled
Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma
Phase 2 Unknown
43 enrolled
Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme
Phase 2 Completed
50 enrolled
Temozolomide in Treating Patients With Brain Metastases
Phase 2 Completed
Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors
Phase 2 Completed
Temozolomide in Treating Patients With Recurrent Malignant Glioma
Phase 2 Completed
Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma
Phase 2 Completed
32 enrolled 8 charts
Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma
Phase 2 Terminated
12 enrolled
Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 2 Completed
27 enrolled
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
Phase 2 Completed
39 enrolled
Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 2 Completed
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
Phase 2 Completed
29 enrolled
Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
Phase 2 Completed
53 enrolled